恆生銀行開戶口 相關
廣告上個月有 超過 1 萬 名用戶曾瀏覽 hk.bankcomm.com
成功開戶並啟動網上銀行服務，送額外10,000MyLink積分! 優惠受條款及細則約束。投資涉及風險。
搜尋結果
Our purpose is to pioneer access for patients by developing and commercializing novel, affordable approaches that address unmet medical need. Our ambition is to be the world's leading and most valued generics company. Mailing Address. Rm 30-101, 30/F, The Gateway Tower 5. 15 Canton Rd. Tsim Sha Tsui Hong Kong. Contact Information.
- Rm 30-101, 30/F, The Gateway Tower 515 Canton RdTsim Sha TsuiHong Kong
- 2881 5811
Special Precautions. Do not administer intravascularly or intradermally. SC administration is not recommended. Not indicated for prevention of primary varicella infection (chickenpox). Appropriate medical treatment & supervision should always be readily available in case of an anaphylactic event following vaccination.
Four Star. Concise Prescribing Info. Contents. Entecavir. Indications/Uses. Chronic HBV infection in adults w/ compensated liver disease & evidence of active viral replication, persistently elevated serum ALT levels & histological evidence of active inflammation &/or fibrosis. Dosage/Direction for Use. Nucleoside-naïve patient 0.5 mg once daily.
Tagrisso FC tab 40 mg. Packing/Price. 30's. Form. Tagrisso FC tab 80 mg. Packing/Price. 30's. Tagrisso (Osimertinib mesylate): Adjuvant treatment after complete tumour resection in adults w/ stage IB-IIIA NSCLC whose tumours have epidermal growth fac.
Administered once daily, taken at the same time every day. Adult 1st wk: 5 mg/day; 2nd wk: 10 mg/day; 3rd wk: 15 mg/day; from 4th wk onwards: 20 mg/day.Max: 20 mg/day. Maintenance: 20 mg/ Effects of L-dopa, dopaminergic agonists & anticholinergics may ...
Adjuvant treatment of germline BRCA-mutated high risk early breast cancer Up to 1 yr, or until disease recurrence, or unacceptable toxicity, whichever occurs 1st. Patient w/ moderate renal impairment (CrCl 31-50 mL/min) 200 mg (two 100-mg tab) bd. Click to view Lynparza detailed prescribing information.
Initial dose should be administered as a 90-min IV infusion. If prior infusion was well tolerated, subsequent doses may be administered as 30-min infusions. Breast cancer 5.4 mg/kg IV infusion once every 3 wk (21-day cycle) until disease progression or unacceptable toxicity. Gastric cancer 6.4 mg/kg IV infusion once every 3 wk (21-day cycle ...
